US Patent 7307096 Combined agents for treatment of glaucoma
All edits
Edits on 16 Sep, 2023
Golden AI
Edits made to:
Infobox (+1 properties)
Infobox
Patent Inventor Names
Tomihisa Yokoyama0
Edits on 1 Sep, 2023
Golden AI
Edits made to:
Article (+362 characters)
Article
Patent abstract
A pharmaceutical composition for the prophylaxis or treatment of glaucoma which comprises an angiotensin II antagonist and at least one compound selected from an adrenaline receptor blocker, a prostaglandin and a carbonic anhydrase inhibitor; and a method for the prophylaxis or treatment of glaucoma by administering the composition to a patient.
Edits on 21 Jul, 2023
Golden AI
Edits made to:
Infobox (-1 properties)
Infobox
Official Website
Edits on 21 May, 2023
Golden AI
Edits made to:
Infobox (+1/-1 properties)
US Patent 07307096 Combined agents for treatment of glaucoma US Patent 7307096 Combined agents for treatment of glaucoma
Infobox
Patent Number
073070960
Patent Number
73070960
Edits on 24 Sep, 2022
Golden AI
Infobox
Is a
Patent Jurisdiction
Patent Number
073070960
Date of Patent
December 11, 2007
0Patent Application Number
101467470
Date Filed
May 16, 2002
0Official Website
Patent Primary Examiner
Edits on 17 Jun, 2022
Golden AI
Edits made to:
Infobox (+1 properties)
Infobox
Website URL
Edits on 23 Nov, 2021
Golden AI
Edits made to:
Infobox (+7 properties)
US Patent 07307096 Combined agents for treatment of glaucoma
Infobox
Is a
Patent jurisdiction
Patent number
07307096
Date of patent
December 11, 2007
Patent application number
10146747
Date Filed
May 16, 2002
Patent primary examiner
Find more entities like US Patent 7307096 Combined agents for treatment of glaucoma
Use the Golden Query Tool to find similar entities by any field in the Knowledge Graph, including industry, location, and more.
By using this site, you agree to our Terms of Service.